Blood-Brain Barrier Permeable Chitosan Oligosaccharides Interfere with β-Amyloid Aggregation and Alleviate β-Amyloid Protein Mediated Neurotoxicity and Neuroinflammation in a Dose- and Degree of Polymerization-Dependent Manner
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blood-Brain Barrier Permeable Chitosan Oligosaccharides Interfere with β-Amyloid Aggregation and Alleviate β-Amyloid Protein Mediated Neurotoxicity and Neuroinflammation in a Dose- and Degree of Polymerization-Dependent Manner
Authors
Keywords
-
Journal
Marine Drugs
Volume 18, Issue 10, Pages 488
Publisher
MDPI AG
Online
2020-09-25
DOI
10.3390/md18100488
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A review on the preparation of chitosan oligosaccharides and application to human health, animal husbandry and agricultural production
- (2019) Xubing Yuan et al. CARBOHYDRATE POLYMERS
- Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme
- (2019) Lynn Jena et al. Drug Delivery and Translational Research
- Chitooligosaccharides and their biological activities: A comprehensive review
- (2018) Fakhra Liaqat et al. CARBOHYDRATE POLYMERS
- Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
- (2018) C. Cheignon et al. Redox Biology
- An Overview of the Protective Effects of Chitosan and Acetylated Chitosan Oligosaccharides against Neuronal Disorders
- (2017) Cui Hao et al. Marine Drugs
- A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
- (2017) Jun Wang et al. Nature Reviews Neurology
- Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies
- (2017) Juan Carlos Polanco et al. Nature Reviews Neurology
- Neuroprotective Effect of Chitosan Oligosaccharide on Hypoxic-Ischemic Brain Damage in Neonatal Rats
- (2017) Wei Wu et al. NEUROCHEMICAL RESEARCH
- Chitosan oligosaccharide: Biological activities and potential therapeutic applications
- (2017) Chatchai Muanprasat et al. PHARMACOLOGY & THERAPEUTICS
- Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review
- (2016) Hena Khanam et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- Self-assembly of the full-length amyloid Aβ42 protein in dimers
- (2016) Yuliang Zhang et al. Nanoscale
- From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery
- (2016) William A. Banks NATURE REVIEWS DRUG DISCOVERY
- Design of LVFFARK and LVFFARK-Functionalized Nanoparticles for Inhibiting Amyloid β-Protein Fibrillation and Cytotoxicity
- (2015) Neng Xiong et al. ACS Applied Materials & Interfaces
- β-Sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis
- (2015) Antonio Francioso et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Acetylated Chitosan Oligosaccharides Act as Antagonists against Glutamate-Induced PC12 Cell Death via Bcl-2/Bax Signal Pathway
- (2015) Cui Hao et al. Marine Drugs
- Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease
- (2015) Sagar H. Barage et al. NEUROPEPTIDES
- Protection against β-amyloid-induced synaptic and memory impairments via altering β-amyloid assembly by bis(heptyl)-cognitin
- (2015) Lan Chang et al. Scientific Reports
- Alzheimer's disease
- (2015) Colin L. Masters et al. Nature Reviews Disease Primers
- Nanomaterials for Reducing Amyloid Cytotoxicity
- (2013) Min Zhang et al. ADVANCED MATERIALS
- Characterization of drug permeability in Caco-2 monolayers by mass spectrometry on a membrane-based microfluidic device
- (2012) Dan Gao et al. LAB ON A CHIP
- Microscale thermophoresis quantifies biomolecular interactions under previously challenging conditions
- (2012) Susanne A.I. Seidel et al. METHODS
- Small-molecule conversion of toxic oligomers to nontoxic β-sheet–rich amyloid fibrils
- (2011) Jan Bieschke et al. Nature Chemical Biology
- A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
- (2011) S. Salloway et al. NEUROLOGY
- Chitosan Modification and Pharmaceutical/Biomedical Applications
- (2010) Jiali Zhang et al. Marine Drugs
- Natural products as a source of Alzheimer's drug leads
- (2010) Philip Williams et al. NATURAL PRODUCT REPORTS
- Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
- (2010) Jorge J Palop et al. NATURE NEUROSCIENCE
- Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease
- (2010) Lars M. Ittner et al. NATURE REVIEWS NEUROSCIENCE
- Glucose transporters in the 21st Century
- (2009) Bernard Thorens et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Small molecule inhibitors of Aβ-aggregation and neurotoxicity
- (2009) Cheryl A. Hawkes et al. DRUG DEVELOPMENT RESEARCH
- CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
- (2009) Cameron R Stewart et al. NATURE IMMUNOLOGY
- Chitooligosaccharides protect cultured hippocampal neurons against glutamate-induced neurotoxicity
- (2008) Songlin Zhou et al. NEUROSCIENCE LETTERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now